Solution reagent APO A1

blood samplefor clinical chemistryfor immunoanalysis

Quantitative determination of Apolipoprotein A1 (APA) in human serum by turbidimetric immunoassay. Product Details Clinical Significance: To examine the relationship of hypertriglyceridemia to coronary artery disease (CAD), we measured serum cholesterol, triglyceride, high density lipoprotein cholesterol (HDL-C) and apolipoproteins (apo) A-I, A-II and B in 82 male patients with angiographically defined CAD and 140 age-matched healthy controls. The CAD patients had significantly lower apo A-I and A-II and HDL-C levels, but had higher apo B and triglyceride levels than the controls. After adjustments of apolipoproteins for serum triglyceride, CAD patients had significantly higher apo B and lower apo A-I and A-II levels than the controls. it is necessary to sub-classify dyslipoproteinemia by serum apolipoprotein levels for predicting the future occurrence of CAD in the general population. Packaging information: Pack Size R1: 2 x 25 ml; R2: 1 x 5 ml; Calibrator: 1 x 1 ml